A 24 month observational study to evaluate the safety of Lucentis (0.5mg) in a cohort of Patients with choroidal neovascularization secondary to age related macular degeneration

Hdl Handle:
http://hdl.handle.net/10147/140742
Title:
A 24 month observational study to evaluate the safety of Lucentis (0.5mg) in a cohort of Patients with choroidal neovascularization secondary to age related macular degeneration
Issue Date:
25-Aug-2011
URI:
http://hdl.handle.net/10147/140742
Ethical Approval:
YES

Full metadata record

DC FieldValue Language
dc.date.accessioned2011-08-25T15:20:41Z-
dc.date.available2011-08-25T15:20:41Z-
dc.date.issued2011-08-25T15:20:41Z-
dc.identifier.urihttp://hdl.handle.net/10147/140742-
dc.titleA 24 month observational study to evaluate the safety of Lucentis (0.5mg) in a cohort of Patients with choroidal neovascularization secondary to age related macular degenerationen
dc.type.qualificationlevelN/Aen
cr.approval.ethicalYESen
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.